What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Roxane
95%DGNews: VIRAMUNE Now Commercially Available for the Treatment of HIV
92%DGNews: Urgent Notice-Drug Recall: Roxane Laboratories Initiates a Nationwide Voluntary Recall of a Single Manufacturing Lot of Azathioprine Tablets in the U.S. and Puerto Rico
91%DGNews: Nationwide Voluntary Recall of 2 Lots of Sodium Polystyrene Sulfonate Suspension in the United States and Puerto Rico
89%DGNews: Drug May Impact Pediatric AIDS
88%DGNews: DG DISPATCH - ICDT-HIV: Marinol (Dronabinol) May Reduce Nausea, Vomiting From HIV Therapy
88%DGNews: Higher Dose Of Duraclon (Clonidine) Now Available For Severe Neuropathic Pain
88%DGNews: FDA To Review AIDS Drug Application
87%DGNews: FDA Approves Cafcit Injection For Apnea In Preterm Infants
87%DGNews: HIV-1 Therapy With Viramune Combination Works in Infants and Children
86%DGNews: DG DISPATCH - AIDS 2000: Drug Maker Promises To Provide Viramune (Nevirapine) To HIV-infected Pregnant Women
85%DGNews: Cafcit (Caffeine Citrate) Approved in U.S. for Pre-Term Infants with Respiratory Problems
84%DGNews: FDA Approves Pediatric Viramune For HIV Treatment
84%DGNews: Reactions Following Disasters Don't Fit Stereotypes
83%DGNews: People Using Viramune In Triple Therapy Achieve HIV Suppression For One Year
82%DGNews: ADA: Maintaining Weight May Improve Survival, Quality of Life For HIV And Cancer Patients
80%DGNews: Viramune, First Drug in Non-Nucleoside Class of Agents, Effective in 1st Year
79%DGNews: Efficacy Of Anti-HIV Drug, Viramune (Nevirapine), Confirmed By Experts
79%DGNews: VIRAMUNE Recommended for Accelerated Approval for HIV Infection
75%DGNews: VIRAMUNE Receives Accelerated Approval To Treat AIDS
73%DGNews: Cafcit (Caffeine Citrate) Safe, Effective For Apnea In Premature Infants
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.